StonvexLoading…
StonvexStonvexStonvexCore line items from AMPY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $37.46M | $263.36M | $206.81M | $140.41M |
Operating Income | $-49.31M | $76.94M | $-17.96M | $8.56M |
Net Income | $-38.12M | $43.97M | $-20.44M | $6.38M |
EPS (Diluted) | $-0.93 | $1.03 | $-0.51 | $0.01 |
Total Assets | $581.11M | $600.90M | $731.36M | $771.31M |
Total Liabilities | $160.54M | $142.18M | $338.38M | $360.00M |
Cash & Equivalents | $41.49M | $60.67M | $0.00 | $0.00 |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 41.29M | 40.72M | 40.48M | 40.40M |